STING1 and metabolic dysfunction-associated steatotic liver disease: Although the effect of DMXAA treatment is not limited to STING activation, the validation that hepatocyte production of mtDNA in response to excessive fat deposition underlies how Kupffer cells are activated by hepatocyte factor(s) to contribute to liver inflammation provides new insights into the inflammatory mechanisms of NAFLD/NASH [54].